The National Labor Relations Board yesterday reestablished the right of an employer to restrict employee use of its email system if it does so on a nondiscriminatory basis. The , issued in the Caesars Entertainment case, overrules the board鈥檚 2014 decision in Purple Communications Inc. and effectively reinstates its position in the 2007 Register Guard case, holding that employees do not have a statutory right to use employers鈥 email and other information technology resources to engage in non-work-related communications. Rather, the board said employers have a right to control the use of their equipment, including their email and other IT systems, and may lawfully restrict the use of those systems as long as they do not discriminate against union or other protected communications. The decision creates an exception for circumstances where the use of employer-provided email is the only reasonable means for employees to communicate with one another on non-working time during the workday. The AHA and Federation of 黑料正能量s had urged the board to consider hospital electronic communication systems as a virtual 鈥減atient care area鈥 and reestablish the previous standard.

Related News Articles

Headline
In the latest issue of AHA's Trustee Insights newsletter, James Liggins, Jr., 2025 AHA Committee on Governance chair and board chair of Bronson Healthcare鈥
Headline
The AHA Center for Health Innovation released a new report to guide hospital and health system executives on using artificial intelligence and AI-powered鈥
Headline
A guide published Jan. 13 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI, Environmental Protection Agency,鈥
Headline
The Department of Health and Human Services Dec. 16 published a final rule implementing certain provisions related to information blocking exceptions. The rule鈥
Headline
The Department of Health and Human Services Dec. 11 published a final rule implementing provisions related to the Trusted Exchange Framework and Common鈥
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex鈥